Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Roederer

Showing results (251-260 of 405) with videos related to

Pageof 41
Sort By:
Plos Pathogens|May 25, 2016
Correction: Targeted Isolation of Antibodies Directed against Major Sites of SIV Env VulnerabilityRosemarie D Mason, Hugh C Welles, Cameron Adams, et al.
Haematologica|April 28, 2018
The early expansion of anergic NKG2A<sup>pos</sup>/CD56<sup>dim</sup>/CD16<sup>neg</sup> natural killer represents a therapeutic target in haploidentical hematopoietic stem cell transplantationAlessandra Roberto, Clara Di Vito, Elisa Zaghi, et al.
The Journal of Experimental Medicine|December 1, 2010
Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infectionChristof Geldmacher, Njabulo Ngwenyama, Alexandra Schuetz, et al.
Nature Medicine|September 20, 2011
A human memory T cell subset with stem cell-like propertiesLuca Gattinoni, Enrico Lugli, Yun Ji, et al.
Journal of Virology|May 17, 2019
CD8β Depletion Does Not Prevent Control of Viral Replication or Protection from Challenge in Macaques Chronically Infected with a Live Attenuated Simian Immunodeficiency VirusMatthew S Sutton, Amy Ellis-Connell, Alexis J Balgeman, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Requirement for Fc effector function is overcome by binding potency for broadly reactive anti-alphavirus antibodiesVictoria Callahan, Matthew S Sutton, Christina L Gardner, et al.
Cell Reports|January 18, 2025
Structural development of the HIV-1 apex-directed PGT145-PGDM1400 antibody lineageRosemarie D Mason, Baoshan Zhang, Nicholas C Morano, et al.
Clinical and Vaccine Immunology : CVI|September 22, 2006
A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trialJulie E Martin, Nancy J Sullivan, Mary E Enama, et al.
Biorxiv : the Preprint Server for Biology|February 15, 2023
Investigation of the Impact of Clonal Hematopoiesis on Severity and Pathophysiology of COVID-19 in Rhesus MacaquesTae-Hoon Shin, Yifan Zhou, Byung-Chul Lee, et al.
NPJ Vaccines|June 1, 2019
Boosting BCG with proteins or rAd5 does not enhance protection against tuberculosis in rhesus macaquesPatricia A Darrah, Robert M DiFazio, Pauline Maiello, et al.
Pageof 41

Showing results (251-260 of 405) with videos related to

Sort By:
Pageof 41
Plos Pathogens|May 25, 2016
Correction: Targeted Isolation of Antibodies Directed against Major Sites of SIV Env VulnerabilityRosemarie D Mason, Hugh C Welles, Cameron Adams, et al.
Haematologica|April 28, 2018
The early expansion of anergic NKG2A<sup>pos</sup>/CD56<sup>dim</sup>/CD16<sup>neg</sup> natural killer represents a therapeutic target in haploidentical hematopoietic stem cell transplantationAlessandra Roberto, Clara Di Vito, Elisa Zaghi, et al.
The Journal of Experimental Medicine|December 1, 2010
Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infectionChristof Geldmacher, Njabulo Ngwenyama, Alexandra Schuetz, et al.
Nature Medicine|September 20, 2011
A human memory T cell subset with stem cell-like propertiesLuca Gattinoni, Enrico Lugli, Yun Ji, et al.
Journal of Virology|May 17, 2019
CD8β Depletion Does Not Prevent Control of Viral Replication or Protection from Challenge in Macaques Chronically Infected with a Live Attenuated Simian Immunodeficiency VirusMatthew S Sutton, Amy Ellis-Connell, Alexis J Balgeman, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Requirement for Fc effector function is overcome by binding potency for broadly reactive anti-alphavirus antibodiesVictoria Callahan, Matthew S Sutton, Christina L Gardner, et al.
Cell Reports|January 18, 2025
Structural development of the HIV-1 apex-directed PGT145-PGDM1400 antibody lineageRosemarie D Mason, Baoshan Zhang, Nicholas C Morano, et al.
Clinical and Vaccine Immunology : CVI|September 22, 2006
A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trialJulie E Martin, Nancy J Sullivan, Mary E Enama, et al.
Biorxiv : the Preprint Server for Biology|February 15, 2023
Investigation of the Impact of Clonal Hematopoiesis on Severity and Pathophysiology of COVID-19 in Rhesus MacaquesTae-Hoon Shin, Yifan Zhou, Byung-Chul Lee, et al.
NPJ Vaccines|June 1, 2019
Boosting BCG with proteins or rAd5 does not enhance protection against tuberculosis in rhesus macaquesPatricia A Darrah, Robert M DiFazio, Pauline Maiello, et al.
Pageof 41